Drugs Information: Nivolumab
Basic Information
|
||
| ID | DDInter1308 | |
| Drug Type | biotech | |
| Molecular Formula | C6362H9862N1712O1995S42 | |
| Molecular Weight | - | |
| Description | Nivolumab is a PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. | |
| ATC Classification | L01XC17 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Nivolumab
| Severity level | ID | Name | Mechanism | Detail |
|---|